Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-25-008001
Filing Date
2025-03-17
Accepted
2025-03-17 16:10:19
Documents
2
Period of Report
2025-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 2603
2 POA_MIRALLES poa_miralles.htm EX-24 8515
  Complete submission text file 0001437749-25-008001.txt   12641
Mailing Address 2235 VIA FRESCA LA JOLLA CA 92037
Business Address
Miralles Gines Diego (Reporting) CIK: 0001773413 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42001 | Film No.: 25744506

Mailing Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Issuer) CIK: 0001855175 (see all company filings)

EIN.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)